Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.97% |
| 2 | Financials | 4.82% |
| 3 | Healthcare | 4.18% |
| 4 | Industrials | 3.64% |
| 5 | Consumer Discretionary | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.11B
| $1.11M | ﹤0.01% |
50,763
-212,604
| -81% | -$4.67M |
|
|
ONC
5227
PUT
BeOne Medicines Ltd
ONC
$39.3B
| $1.11M | ﹤0.01% |
8,400
-2,300
| -21% | -$310K |
|
5228
CALL
Acadia Healthcare
ACHC
$2.87B
| $1.11M | ﹤0.01% |
37,800
-107,100
| -74% | -$3.03M |
|
5229
Installed Building Products
IBP
$6.39B
| $1.11M | ﹤0.01% |
22,825
+3,122
| +16% | +$134K |
|
5230
First Trust Emerging Markets Equity Select ETF
RNEM
$16.8M
| $1.11M | ﹤0.01% |
+21,759
| New | +$1.11M |
|
|
AERI
5231
CALL
DELISTED
Aerie Pharmaceuticals
AERI
| $1.11M | ﹤0.01% |
23,300
-21,900
| -48% | -$964K |
|
5232
PUT
Evolus
EOLS
$538M
| $1.11M | ﹤0.01% |
+49,000
| New | +$1.06M |
|
5233
PUT
Orthofix Medical
OFIX
$421M
| $1.11M | ﹤0.01% |
19,600
-8,100
| -29% | -$455K |
|
5234
Piper Sandler
PIPR
$5.41B
| $1.11M | ﹤0.01% |
+60,708
| New | +$1.08M |
|
5235
PUT
Turkcell
TKC
$4.75B
| $1.1M | ﹤0.01% |
206,200
+139,400
| +209% | +$887K |
|
5236
CALL
Wyndham Hotels & Resorts
WH
$5.46B
| $1.1M | ﹤0.01% |
22,100
-46,400
| -68% | -$2.35M |
|
|
VSTO
5237
DELISTED
Vista Outdoor Inc.
VSTO
| $1.1M | ﹤0.01% |
137,806
+29,759
| +28% | +$291K |
|
5238
ProShares UltraShort Energy
DUG
$18.1M
| $1.1M | ﹤0.01% |
1,516
+32
| +2% | +$25.2K |
|
5239
CALL
Nice
NICE
$5.99B
| $1.1M | ﹤0.01% |
9,000
-4,600
| -34% | -$518K |
|
5240
PUT
Steris
STE
$22.7B
| $1.1M | ﹤0.01% |
8,600
+2,100
| +32% | +$247K |
|
|
BNFT
5241
PUT
DELISTED
Benefitfocus, Inc.
BNFT
| $1.1M | ﹤0.01% |
22,200
+15,100
| +213% | +$772K |
|
|
CBLK
5242
CALL
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $1.1M | ﹤0.01% |
78,800
+4,300
| +6% | +$61.3K |
|
5243
CALL
Enanta Pharmaceuticals
ENTA
$383M
| $1.1M | ﹤0.01% |
11,500
+400
| +4% | +$35.9K |
|
5244
PUT
Puma Biotechnology
PBYI
$456M
| $1.1M | ﹤0.01% |
28,300
-62,000
| -69% | -$1.89M |
|
5245
CALL
Star Bulk Carriers
SBLK
$3.24B
| $1.1M | ﹤0.01% |
166,900
+4,000
| +2% | +$32.2K |
|
5246
CALL
Manhattan Associates
MANH
$11.5B
| $1.1M | ﹤0.01% |
19,900
-4,700
| -19% | -$240K |
|
5247
Invesco Large Cap Value ETF
PWV
$1.8B
| $1.1M | ﹤0.01% |
30,967
+1,740
| +6% | +$61.3K |
|
5248
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.37M
| $1.1M | ﹤0.01% |
+19,007
| New | +$1.08M |
|
|
RESI
5249
CALL
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.09M | ﹤0.01% |
118,100
+54,300
| +85% | +$566K |
|
5250
Carlyle Group
CG
$17.6B
| $1.09M | ﹤0.01% |
59,826
+4,625
| +8% | +$84K |
|
Similar funds
Ken Griffin's Q1 2019 Portfolio in Review
As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $13B in Q1 2019, closing 1,251 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 4.8% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.
- Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Ken Griffin opened 1,429 new positions and closed 1,251 in Q1 2019.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.